Ferring Pharmaceuticals is a private, research-driven specialty biopharmaceutical company active in global markets. The company identifies, develops and markets innovative products in the fields of endocrinology, gastroenterology, infertility, obstetrics, urology and osteoarthritis. In recent years Ferring has expanded beyond its traditional European base, with over 3,700 employees worldwide, it operates subsidiaries in over 45 countries and makes its products available in more than 70 countries.

Ferring Research Institute, Inc. (FRI) is the center of excellence for peptide research for Ferring Pharmaceuticals. Established in 1996, FRI now occupies a state-of-the-art research facility in Sorrento Valley, San Diego. Located in the heart of the Southern California biopharmaceutical community, the center has attracted a diverse group of highly skilled professionals representing over fifteen countries of origin.

Presently Ferring offers full-time employees (for calendar year 2010) up to 9 paid holidays plus winter company closure from December 27th, 2010 through December 31st, 2010. Ferring also offers a generous vacation plan of 15 days per year, paid sick time equivalent to 64 hours is made available at the beginning of each calendar year and prorated at the start of new employment. A matching 401(k) program, with immediate enrollment available to all qualifying employees, 100% employer-paid employee coverage (80% employer-paid dependent coverage) medical, dental, vision, short-term and long-term disability benefits, employee assistance program, health and dependant care flexibility spending account plan, accidental death and dismemberment coverage along with a very generous infertility benefit program, just to name a few!
Ferring Pharmaceuticals Celebrates 60 Years
Ferring is proud to be an Equal Opportunity Employer